BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16475024)

  • 1. Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region.
    Katabami K; Mizuno H; Sano R; Saito Y; Ogura M; Itoh S; Tsuji T
    Clin Exp Metastasis; 2005; 22(7):539-48. PubMed ID: 16475024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.
    Giannelli G; Fransvea E; Marinosci F; Bergamini C; Colucci S; Schiraldi O; Antonaci S
    Am J Pathol; 2002 Jul; 161(1):183-93. PubMed ID: 12107103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of transcription factor Ets-1 in the expression of the α3 integrin subunit gene.
    Kamoshida G; Matsuda A; Katabami K; Kato T; Mizuno H; Sekine W; Oku T; Itoh S; Tsuiji M; Hattori Y; Maitani Y; Tsuji T
    FEBS J; 2012 Dec; 279(24):4535-46. PubMed ID: 23094960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the promoter for the alpha3 integrin gene in various tumor cell lines: roles of the Ets- and Sp-family of transcription factors.
    Katabami K; Kato T; Sano R; Ogura M; Mizuno H; Itoh S; Tsuji T
    J Cell Biochem; 2006 Feb; 97(3):530-43. PubMed ID: 16211576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
    Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
    Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of alpha3beta1 integrin.
    Mizuno H; Ogura M; Saito Y; Sekine W; Sano R; Gotou T; Oku T; Itoh S; Katabami K; Tsuji T
    Biochim Biophys Acta; 2008 Mar; 1780(3):564-70. PubMed ID: 17997226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells.
    Kim DJ; Lee DC; Yang SJ; Lee JJ; Bae EM; Kim DM; Min SH; Kim SJ; Kang DC; Sang BC; Myung PK; Park KC; Yeom YI
    Biochem Biophys Res Commun; 2008 Sep; 373(4):521-7. PubMed ID: 18586005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells.
    Taki M; Verschueren K; Yokoyama K; Nagayama M; Kamata N
    Int J Oncol; 2006 Feb; 28(2):487-96. PubMed ID: 16391805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.
    Saito D; Kyakumoto S; Chosa N; Ibi M; Takahashi N; Okubo N; Sawada S; Ishisaki A; Kamo M
    J Biochem; 2013 Mar; 153(3):303-15. PubMed ID: 23248240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of chemokine receptor CXCR4 expression by transforming growth factor-β1 in human basal cell carcinoma cells.
    Chu CY; Sheen YS; Cha ST; Hu YF; Tan CT; Chiu HC; Chang CC; Chen MW; Kuo ML; Jee SH
    J Dermatol Sci; 2013 Nov; 72(2):123-33. PubMed ID: 23856244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
    Giannelli G; Bergamini C; Fransvea E; Sgarra C; Antonaci S
    Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1 stimulates contraction of human glioblastoma cell-mediated collagen lattice through enhanced alpha2 integrin expression.
    Miyake K; Kimura S; Nakanishi M; Hisada A; Hasegawa M; Nagao S; Abe Y
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):18-28. PubMed ID: 10744032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR; Qi L; Higgins PJ
    J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling.
    Feng XX; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Tian DA
    PLoS One; 2013; 8(11):e79857. PubMed ID: 24260309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
    de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
    Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
    Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
    FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.
    Fransvea E; Mazzocca A; Antonaci S; Giannelli G
    Hepatology; 2009 Mar; 49(3):839-50. PubMed ID: 19115199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
    Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
    J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.